{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T12:56:53Z","timestamp":1779886613289,"version":"3.53.1"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T00:00:00Z","timestamp":1693872000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Radiat Oncol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Volumetric modulated arc therapy (VMAT) for locally advanced rectal cancer (LARC) has emerged as a promising technique, but the planning process can be time-consuming and dependent on planner expertise. We aimed to develop a fully automated VMAT planning program for LARC and evaluate its feasibility and efficiency.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>A total of 26 LARC patients who received VMAT treatment and the computed tomography (CT) scans were included in this study. Clinical target volumes and organs at risk were contoured by radiation oncologists. The automatic planning program, developed within the Raystation treatment planning system, used scripting capabilities and a Python environment to automate the entire planning process. The automated VMAT plan (auto-VMAT) was created by our automated planning program with the 26 CT scans used in the manual VMAT plan (manual-VMAT) and their regions of interests. Dosimetric parameters and time efficiency were compared between the auto-VMAT and the manual-VMAT created by experienced planners. All results were analyzed using the Wilcoxon signed-rank sum test.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The auto-VMAT achieved comparable coverage of the target volume while demonstrating improved dose conformity and uniformity compared with the manual-VMAT. V30 and V40 in the small bowel were significantly lower in the auto-VMAT compared with those in the manual-VMAT (p\u2009&lt;\u20090.001 and &lt;\u20090.001, respectively); the mean dose of the bladder was also significantly reduced in the auto-VMAT (p\u2009&lt;\u20090.001). Furthermore, auto-VMAT plans were consistently generated with less variability in quality. In terms of efficiency, the auto-VMAT markedly reduced the time required for planning and expedited plan approval, with 93% of cases approved within one day.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>We developed a fully automatic feasible VMAT plan creation program for LARC. The auto-VMAT maintained target coverage while providing organs at risk dose reduction. The developed program dramatically reduced the time to approval.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13014-023-02334-0","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T12:02:31Z","timestamp":1693915351000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Fully automated volumetric modulated arc therapy planning for locally advanced rectal cancer: feasibility and efficiency"],"prefix":"10.1186","volume":"18","author":[{"given":"Kouta","family":"Hirotaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kento","family":"Tomizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajime","family":"Oyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay","family":"Raturi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masashi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeji","family":"Sakae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,9,5]]},"reference":[{"key":"2334_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and Mortality Worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71:209\u201349.","journal-title":"CA Cancer J Clin"},{"key":"2334_CR2","first-page":"226","volume":"35","author":"A Affleck","year":"2022","unstructured":"Affleck A, Koprowski MA, Nabavizadeh N, Tsikitis VL. The evolution of rectal cancer treatment: the journey to total neoadjuvant therapy and organ preservation. Ann Gastroenterol. 2022;35:226\u201333.","journal-title":"Ann Gastroenterol"},{"key":"2334_CR3","doi-asserted-by":"crossref","unstructured":"Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet (London, England). England; 1986;1:1479\u201382.","DOI":"10.1016\/S0140-6736(86)91510-2"},{"key":"2334_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/cancers12123611","volume":"12","author":"F Papaccio","year":"2020","unstructured":"Papaccio F, Rosell\u00f3 S, Huerta M, Gambardella V, Tarazona N, Fleitas T, et al. Neoadjuvant chemotherapy in locally advanced rectal cancer. Cancers (Basel). 2020;12:1\u201312.","journal-title":"Cancers (Basel)"},{"key":"2334_CR5","doi-asserted-by":"crossref","unstructured":"Wo JY, Anker CJ, Ashman JB, Bhadkamkar NA, Bradfield L, Chang DT et al. Radiation Therapy for Rectal Cancer: Executive Summary of an ASTRO Clinical Practice Guideline. Pract. Radiat. Oncol. United States; 2021. p.\u00a013\u201325.","DOI":"10.1016\/j.prro.2020.08.004"},{"key":"2334_CR6","doi-asserted-by":"crossref","unstructured":"Appelt AL, Sebag-Montefiore D. Technological advances in radiotherapy of rectal cancer. Curr Opin Oncol [Internet]. 2016;28:353\u20138. Available from: http:\/\/journals.lww.com\/00001622-201607000-00016.","DOI":"10.1097\/CCO.0000000000000306"},{"key":"2334_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2017.00225","volume":"7","author":"A Regnier","year":"2017","unstructured":"Regnier A, Ulbrich J, M\u00fcnch S, Oechsner M, Wilhelm D, Combs SE, et al. Comparative analysis of efficacy, toxicity, and patient-reported outcomes in rectal cancer patients undergoing preoperative 3D conformal radiotherapy or VMAT. Front Oncol. 2017;7:1\u20138.","journal-title":"Front Oncol"},{"key":"2334_CR8","doi-asserted-by":"publisher","unstructured":"Stuyck C, Wegge M, Bulens P, Joye I, Haustermans K. Moderate dose escalation with volumetric modulated arc therapy improves outcome in rectal cancer. Acta Oncol (Madr) [Internet]. Informa UK Limited, trading as Taylor & Francis Group; 2017;56:1501\u20136. https:\/\/doi.org\/10.1080\/0284186X.2017.1350286.","DOI":"10.1080\/0284186X.2017.1350286"},{"key":"2334_CR9","doi-asserted-by":"publisher","unstructured":"Dr\u00f6ge LH, Weber HE, Guhlich M, Leu M, Conradi LC, Gaedcke J et al. Reduced toxicity in the treatment of locally advanced rectal cancer: A comparison of volumetric modulated arc therapy and 3D conformal radiotherapy. BMC Cancer [Internet]. BMC Cancer; 2015;15:1\u20138. https:\/\/doi.org\/10.1186\/s12885-015-1812-x.","DOI":"10.1186\/s12885-015-1812-x"},{"key":"2334_CR10","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1016\/j.ijrobp.2007.11.040","volume":"71","author":"HT Chung","year":"2008","unstructured":"Chung HT, Lee B, Park E, Lu JJ, Xia P. Can all Centers Plan intensity-modulated Radiotherapy (IMRT) effectively? An external audit of dosimetric comparisons between Three-Dimensional Conformal Radiotherapy and IMRT for Adjuvant Chemoradiation for gastric Cancer. Int J Radiat Oncol Biol Phys. 2008;71:1167\u201374.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2334_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.571644","volume":"10","author":"J Chen","year":"2020","unstructured":"Chen J, Dai J, Nobah A, Bai S, Bi N, Lai Y, et al. A special report on 2019 International Planning Competition and a comprehensive analysis of its results. Front Oncol. 2020;10:1\u201311.","journal-title":"Front Oncol"},{"key":"2334_CR12","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1016\/j.prro.2011.11.012","volume":"2","author":"BE Nelms","year":"2012","unstructured":"Nelms BE, Robinson G, Markham J, Velasco K, Boyd S, Narayan S, et al. Variation in external beam treatment plan quality: an inter-institutional study of planners and planning systems. Pract Radiat Oncol United States. 2012;2:296\u2013305.","journal-title":"Pract Radiat Oncol United States"},{"key":"2334_CR13","doi-asserted-by":"publisher","first-page":"2996","DOI":"10.1200\/JCO.2009.27.4498","volume":"28","author":"LJ Peters","year":"2010","unstructured":"Peters LJ, O\u2019Sullivan B, Giralt J, Fitzgerald TJ, Trotti A, Bernier J, et al. Critical impact of radiotherapy protocol compliance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J Clin Oncol off J Am Soc Clin Oncol United States. 2010;28:2996\u20133001.","journal-title":"J Clin Oncol off J Am Soc Clin Oncol United States"},{"key":"2334_CR14","doi-asserted-by":"crossref","unstructured":"Hussein M, Heijmen BJM, Verellen D, Nisbet A. Automation in intensity modulated radiotherapy treatment planning-a review of recent innovations. Br J Radiol. 2018;91.","DOI":"10.1259\/bjr.20180270"},{"key":"2334_CR15","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1002\/acm2.12679","volume":"20","author":"L Lu","year":"2019","unstructured":"Lu L, Sheng Y, Donaghue J, Liu Shen Z, Kolar M, Wu QJ, et al. Three IMRT advanced planning tools: a multi-institutional side-by-side comparison. J Appl Clin Med Phys. 2019;20:65\u201377.","journal-title":"J Appl Clin Med Phys"},{"key":"2334_CR16","doi-asserted-by":"publisher","unstructured":"Wu H, Jiang F, Yue H, Zhang H, Wang K, Zhang Y. Applying a RapidPlan model trained on a technique and orientation to another: A feasibility and dosimetric evaluation. Radiat Oncol [Internet]. Radiation Oncology; 2016;11:1\u20137. https:\/\/doi.org\/10.1186\/s13014-016-0684-9.","DOI":"10.1186\/s13014-016-0684-9"},{"key":"2334_CR17","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1120\/jacmp.v17i6.6410","volume":"17","author":"H Wu","year":"2016","unstructured":"Wu H, Jiang F, Yue H, Li S, Zhang Y. A dosimetric evaluation of knowledge-based VMAT planning with simultaneous integrated boosting for rectal cancer patients. J Appl Clin Med Phys. 2016;17:78\u201385.","journal-title":"J Appl Clin Med Phys"},{"key":"2334_CR18","doi-asserted-by":"publisher","unstructured":"Song Y, Wang Q, Jiang X, Liu S, Zhang Y, Bai S. Fully automatic volumetric modulated arc therapy plan generation for rectal cancerAutomatic rectal VMAT planning. Radiother Oncol [Internet]. Elsevier Ireland Ltd; 2016;119:531\u20136. https:\/\/doi.org\/10.1016\/j.radonc.2016.04.010.","DOI":"10.1016\/j.radonc.2016.04.010"},{"key":"2334_CR19","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1120\/jacmp.v17i1.5901","volume":"17","author":"I Hazell","year":"2016","unstructured":"Hazell I, Bzdusek K, Kumar P, Hansen CR, Bertelsen A, Eriksen JG, et al. Automatic planning of head and neck treatment plans. J Appl Clin Med Phys. 2016;17:272\u201382.","journal-title":"J Appl Clin Med Phys"},{"key":"2334_CR20","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1007\/s00066-017-1150-9","volume":"193","author":"S Speer","year":"2017","unstructured":"Speer S, Klein A, Kober L, Weiss A, Yohannes I, Bert C. Automatisierte Bestrahlungsplanung: Auswertung von mit Pinnacle3 via Scripting und Auto-Planning erzeugten Bestrahlungspl\u00e4nen von Patienten mit Kopf-Hals-Tumor. Strahlentherapie und Onkol. 2017;193:656\u201365.","journal-title":"Strahlentherapie und Onkol"},{"key":"2334_CR21","doi-asserted-by":"publisher","unstructured":"R\u00f8nde HS, Wee L, Pl\u00f8en J, Appelt AL. Feasibility of preference-driven radiotherapy dose treatment planning to support shared decision making in anal cancer. Acta Oncol (Madr) [Internet]. Informa UK Limited, trading as Taylor & Francis Group; 2017;56:1277\u201385. https:\/\/doi.org\/10.1080\/0284186X.2017.1315174.","DOI":"10.1080\/0284186X.2017.1315174"},{"key":"2334_CR22","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1120\/jacmp.v16i3.5410","volume":"16","author":"S Ghandour","year":"2015","unstructured":"Ghandour S, Matzinger O, Pachoud M. Volumetric-modulated arc therapy planning using multicriteria optimization for localized prostate cancer. J Appl Clin Med Phys. 2015;16:258\u201369.","journal-title":"J Appl Clin Med Phys"},{"key":"2334_CR23","doi-asserted-by":"crossref","unstructured":"Gleeson IAN, Bolger N, Chun H, Hutchinson K. Implementation of automated personalised breast radiotherapy planning techniques with scripting in Raystation. 2023.","DOI":"10.1259\/bjr.20220707"},{"key":"2334_CR24","doi-asserted-by":"publisher","unstructured":"Lou Z, Cheng C, Mao R, Li D, Tian L, Li B et al. Physica Medica A novel automated planning approach for multi-anatomical sites cancer in Raystation treatment planning system. Phys Medica [Internet]. Elsevier Ltd; 2023;109:102586. https:\/\/doi.org\/10.1016\/j.ejmp.2023.102586.","DOI":"10.1016\/j.ejmp.2023.102586"},{"key":"2334_CR25","doi-asserted-by":"crossref","unstructured":"Garofalo MC, Hong T, Hospital MG, Bendell J, North A, Krishnan S, et al. Radiation Therapy Oncology Group Rtog 0822 a phase ii evaluation of Preoperative Chemoradiotherapy utilizing intensity modulated Radiation Therapy (Imrt) in Combination with Capecitabine and Oxaliplatin. for Patients With Locally Advanced; 2011.","DOI":"10.1016\/j.ijrobp.2011.06.008"},{"key":"2334_CR26","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1118\/1.3276775","volume":"37","author":"AL McNiven","year":"2010","unstructured":"McNiven AL, Sharpe MB, Purdie TG. A new metric for assessing IMRT modulation complexity and plan deliverability. Med Phys. 2010;37:505\u201315.","journal-title":"Med Phys"},{"key":"2334_CR27","doi-asserted-by":"publisher","first-page":"7118","DOI":"10.1002\/mp.15854","volume":"49","author":"JK Udupa","year":"2022","unstructured":"Udupa JK, Liu T, Jin C, Zhao L, Odhner D, Tong Y, et al. Combining natural and artificial intelligence for robust automatic anatomy segmentation: application in neck and thorax auto-contouring. Med Phys. 2022;49:7118\u201349.","journal-title":"Med Phys"},{"key":"2334_CR28","doi-asserted-by":"publisher","unstructured":"Mackay K, Bernstein D, Glocker B, Kamnitsas K, Taylor A. A Review of the Metrics Used to Assess Auto-Contouring Systems in Radiotherapy. Clin Oncol [Internet]. The Authors; 2023;35:354\u201369. https:\/\/doi.org\/10.1016\/j.clon.2023.01.016.","DOI":"10.1016\/j.clon.2023.01.016"},{"key":"2334_CR29","doi-asserted-by":"publisher","first-page":"4209","DOI":"10.1118\/1.4947547","volume":"43","author":"MS Huq","year":"2016","unstructured":"Huq MS, Fraass BA, Dunscombe PB, Gibbons JP, Ibbott GS, Mundt AJ, et al. The report of Task Group 100 of the AAPM: application of risk analysis methods to radiation therapy quality management. Med Phys. 2016;43:4209\u201362.","journal-title":"Med Phys"}],"container-title":["Radiation Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02334-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13014-023-02334-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13014-023-02334-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,18]],"date-time":"2023-11-18T09:27:21Z","timestamp":1700299641000},"score":1,"resource":{"primary":{"URL":"https:\/\/ro-journal.biomedcentral.com\/articles\/10.1186\/s13014-023-02334-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,5]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2334"],"URL":"https:\/\/doi.org\/10.1186\/s13014-023-02334-0","relation":{},"ISSN":["1748-717X"],"issn-type":[{"value":"1748-717X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,5]]},"assertion":[{"value":"14 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The contents of the study, including the investigation procedure and the handling of patient information, were approved by the institutional review board of the National Cancer Center Hospital East (IRB No. 2018-076). Informed consent was not required for this planning study on anonymized patient data.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"147"}}